Please login to the form below

Not currently logged in
Email:
Password:

ABPI backs value based pricing

UK industry organisation voices its support for government proposals on valuing medicines as consultation period comes to a close

The Association of the British Pharmaceutical Industry (ABPI) has given its backing to UK government proposals to move to a system of value based pricing (VBP) for medicines.

Unveiling its response to the government's consultation on VBP at a press conference in London yesterday (March 14), the ABPI said that it strongly supported the principle for value to reflect the level of innovation and be based on wider issues, especially those that mattered most to patients.

It added that it wanted the role of research and development to be fully reflected in the future system.

The ABPI's response included three key points: that VBP must be integrated with the current pricing scheme for existing products; that the NHS needed to play a key role and ensure that value-proven medicines were used by clinicians; and that the NHS Commissioning Board should be involved in the development of proposals for VBP to secure medicines access and uptake.

Richard Barker, ABPI director general, said: "Value based pricing needs to be approached with extreme care. It should not be designed in isolation. The UK plays a leading role in this area and the rest of the world will be looking at us to see if we understand innovation and whether our system works."

Patient group National Voices also welcomed the government's objective, but said that there was still a long way to go in the policy development process. This became clearer as the event went on, as the ABPI revealed that the most important details, such as who would be involved in future price negotiations and the pricing structure itself, had yet to be discussed.

The government launched the consultation on December 16; it closes on March 17.

15th March 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics